Charles K Gayer insider trades
Open-market stock purchases and sales by Charles K Gayer, President and CCO at Biocryst Pharmaceuticals Inc, from SEC Form 4 filings since Dec 15, 2020.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +84%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 22, 2025 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | — |
| Dec 22, 2025 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | — |
| Dec 22, 2025 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | — |
| Dec 19, 2025 | BCRX Biocryst Pharmaceuticals Inc | Sold (not open market) | $85K |
| Dec 17, 2025 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | — |
| Dec 17, 2025 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | — |
| Dec 12, 2025 | BCRX Biocryst Pharmaceuticals Inc | Sold (not open market) | $61.9K |
Companies traded
- BCRX Biocryst Pharmaceuticals Inc: 1 buy, 1 sale, last Dec 22, 2025